NCT04173910 is a clinical trial of Ultrasound LPEC/Sellick in Carotid Occlusion, sponsored by University of Liege.

Who is sponsoring NCT04173910?

NCT04173910 is sponsored by University of Liege.

What drugs are being tested in NCT04173910?

Interventions in NCT04173910: Ultrasound LPEC/Sellick.

What condition does NCT04173910 study?

NCT04173910 studies Carotid Occlusion.

Is NCT04173910 still recruiting?

NCT04173910 is currently completed. Last updated 6 October 2020.

Last reviewed 2020-10-06 · How we verify

NCT04173910

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Carotid Artery Analysis During an LPEC Manoeuvre

Completed Last updated 6 October 2020

What this trial tests

trial testing Ultrasound LPEC/Sellick in Carotid Occlusion in 50 participants. Completed in 1 August 2020.

Timeline

15 June 2020

Primary endpoint
15 July 2020

1 August 2020

Quick facts

Lead sponsor	University of Liege
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	15 June 2020
Primary completion	15 July 2020
Estimated completion	1 August 2020
Sites	1 location across Belgium

Drugs / interventions tested

Ultrasound LPEC/Sellick

Conditions studied

Carotid Occlusion — all drugs for Carotid Occlusion →

Sponsor

University of Liege

Who can join

Adults 18 to 90, any sex, with Carotid Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Verify in ultrasound the impact of a Sellick and LPEC manoeuvre in terms of compression of the carotid artery and decrease in vascular flow.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carotid Occlusion

Currently open trials in the same condition.

NCT06511089 — Carotid Artery Stenting During Endovascular Treatment of Acute Stroke · Phase 3 · recruiting

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04173910 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 6 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04173910.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing